Immunosuppressive Factors in Ascites Fluids From Ovarian Cancer Patients

No abstract is available for this paper.

• Publication year

  1984

• Venue

  American Journal of Reproductive Immunology

• Publication date

  1984-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1600-0897.1984.tb00133.xPMID 6528882
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• “Membrane‐Associated” Immunoglobulins in Cyst and Ascites Fluids of Ovarian Cancer Patients *

  1983cited by this paper
• Purification and characterization of an immunosuppressive factor from ovarian cancer ascites fluid

  1981cited by this paper
• Partial purification and characterization of a lymphocyte-inhibitory factor(s) in ascitic fluids from ovarian cancer patients.

  1980cited by this paper
• The Influence of α-Fetoprotein on Moloney Sarcoma Virus Oncogenesis: Evidence for Generation of Antigen Nonspecific Suppressor T Cells

  1978cited by this paper
• In vivo and in vitro studies on nonspecific blocking factors of host origin in cancer patients. Role of plasma exchange as an immunotherapeutic modality.

  1978cited by this paper
• Immunosuppressive activity and tissue polypeptide antigen content of human ascitic fluids.

  1978cited by this paper
• Inhibition of in vitro lymphocyte function by cystic and ascitic fluids from ovarian cancer patients.

  1977cited by this paper
• Immunosuppressive activity of ascitic fluid from patients with cancer metastatic to the peritoneum.

  1977cited by this paper
• Immunosuppressive factors in serum of patients with gastric carcinoma.

  1977cited by this paper
• Host control of tumor growth.

  1977cited by this paper
• Isolation of an immunosuppressive peptide fraction from the serum of cancer patients.

  1975cited by this paper
• Suppression of the immune response by alpha-fetoprotein on the primary and secondary antibody response

  1975cited by this paper
• Lymphocyte E rosette inhibitory factor: a regulatory serum lipoprotein

  1975cited by this paper
• Inhibition of Tumor-Induced Lymphocyte Blastogenesis by a Factor or Factors Associated with Peripheral Leukocytes

  1974cited by this paper
• Suppression of the mitogenic response to phytohemagglutinin in malignant neoplasia: correlation with clinical stage and therapy.

  1974cited by this paper
• Association of anergy with an immunosuppressive peptide fraction in the serum of patients with cancer.

  1974cited by this paper
• Isolation of an immunosuppressive peptide fraction from human plasma.

  1973cited by this paper
• Impaired responsiveness of lymphocytes and serum-inhibitory factors in patients with cancer.

  1973cited by this paper
• Lymphocyte reactivity in cancer patients: Correlation with tumor histology and clinical stage

  1973cited by this paper
• Impaired lymphocyte response to allogeneic cultured lymphoid cells in patients with lung cancer.

  1972cited by this paper
• Lymphocyte Sensitization in Advanced Malignant Disease: A Study of Serum Lymphocyte Depressive Factor

  1972cited by this paper
• Impaired immunologic reactivity and recurrence following cancer surgery

  1970cited by this paper

• Peritoneal NK cells are responsive to IL-15 and percentages are correlated with outcome in advanced ovarian cancer patients

  2018cites this paper
• IL-15 super-agonist (ALT-803) enhances natural killer (NK) cell function against ovarian cancer.

  2017cites this paper
• Characterization of Immunosuppressive Properties of Malignant Ascites in Ovarian Carcinoma

  2016cites this paper
• Immunological changes in the ascites of cancer patients after intraperitoneal administration of the bispecific antibody catumaxomab (anti-EpCAM×anti-CD3).

  2015cites this paper
• Ovarian/Primary Peritoneal Carcinoma

  2012cites this paper
• Generation of lymphokine-activated killer cells in human ovarian carcinoma ascitic fluid: Identification of transforming growth factor-β as a suppressive factor

  2005cites this paper
• Tumor-associated macrophages as a source of functional dendritic cells in ovarian cancer patients.

  2002cites this paper
• Tumor-reactive immunoglobulins in ovarian cancer: diagnostic and therapeutic significance? (review).

  1998cites this paper
• Interleukin-2 activation of cytotoxic cells in postmastectomy seroma.

  1996cites this paper
• Production of a Suppressor of Lymphocyte Proliferation by Two Human Oral Carcinoma Cell Lines

  1992cites this paper
• Impaired Susceptibility of Human Trophoblast to MHC Nonrestricted Killer Cells: Implication in the Maternal‐Fetal Relationship

  1989cites this paper
• Soluble immunosuppressor factors in human cancer

  1988cites this paper
• Microphotometric Determination of Protein Thiols and Disulphides in Tissue Samples from the Human Uterine Cervix and the Skin Reveal a “Field Effect” in the Surroundings of Benign and Malignant Tumours

  1988cites this paper
• Effect of a soluble factor secreted from cultured human trophoblast cells on in vitro lymphocyte reactions.

  1987cites this paper